title: Retreatment with 90Y-labelled ibritumomab tiuxetan in a patient with follicular lymphoma who had previously responded to treatment.
authors.affiliation: Department of Medical Oncology, Antoine-Lacassagne Centre, Nice, France.
authors.forename: Frederic
authors.initials: F
authors.lastname: Peyrade
authors.forename: Antoine
authors.initials: A
authors.lastname: Italiano
authors.forename: Xavier
authors.initials: X
authors.lastname: Fontana
authors.forename: Isabelle
authors.initials: I
authors.lastname: Peyrottes
authors.forename: Antoine
authors.initials: A
authors.lastname: Thyss
mesh_terms: D000368:Aged; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D006801:Humans; D008224:Lymphoma, Follicular / Q000532:radiotherapy*; D008297:Male; D009364:Neoplasm Recurrence, Local / Q000532:radiotherapy; D016499:Radioimmunotherapy; D019233:Retreatment; D015021:Yttrium Radioisotopes / Q000627:therapeutic use
chemical_list: D000911:Antibodies, Monoclonal; D015021:Yttrium Radioisotopes; C422802:ibritumomab tiuxetan